The long and expensive process of discovering new drugs affects many people, including pharmaceutical companies, researchers, patients, and healthcare systems. Companies spend a lot of money on research, but many drug candidates fail, leading to financial losses. Researchers often spend too much time on manual testing and simulations, which can slow down progress. Patients, especially those with serious illnesses, may have to wait longer for effective treatments. Our solution uses AI and machine learning to make the drug discovery process faster and cheaper, improving the chances of success for new drugs. This will help researchers focus on innovation, allow patients to access new treatments sooner, and reduce the strain on healthcare systems. Overall, our approach aims to benefit everyone by bringing effective drugs to market more quickly.